Literature DB >> 3337912

Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease.

C R Zerez1, N A Lachant, S J Lee, K R Tanaka.   

Abstract

RBCs from individuals with sickle cell disease are more susceptible to oxidant damage. Because key antioxidant defense reactions are linked to the pyridine nucleotides nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), we tested the hypothesis that the RBC redox potential as manifested by the NADH/[NAD+ + NADH] and NADPH/[NADP+ + NADPH] ratios is decreased in sickle erythrocytes. Our data demonstrate that sickle RBCs have a significant decrease in the NADH/[NAD+ + NADH] ratio compared with normal RBCs (P less than .00005). Interestingly, sickle RBCs also had a significant increase in total NAD content compared with normal RBCs (P less than .00005). In contrast, although sickle RBCs had a significant increase in the total NADP content compared with normal RBCs (P less than .00005), sickle RBCs had no significant alteration in the NADPH/[NADP+ + NADPH] ratio. High reticulocyte controls demonstrated that these changes were not related to cell age. Thus, sickle RBCs have a decrease in NAD redox potential that may be a reflection of their increased oxidant sensitivity. The changes in these pyridine nucleotides may have further metabolic consequences for the sickle erythrocyte.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337912

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  L-glutamine for sickle cell disease: Knight or pawn?

Authors:  Alina Sadaf; Charles T Quinn
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-27

2.  Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity.

Authors:  Stephen C Rogers; Jerlinda G C Ross; Andre d'Avignon; Lindsey B Gibbons; Vered Gazit; Mojibade N Hassan; Dylan McLaughlin; Sherraine Griffin; Tara Neumayr; Malcolm Debaun; Michael R DeBaun; Allan Doctor
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

3.  Assessment of NAD+metabolism in human cell cultures, erythrocytes, cerebrospinal fluid and primate skeletal muscle.

Authors:  Tyler G Demarest; Gia Thinh D Truong; Jacqueline Lovett; Joy G Mohanty; Julie A Mattison; Mark P Mattson; Luigi Ferrucci; Vilhelm A Bohr; Ruin Moaddel
Journal:  Anal Biochem       Date:  2019-02-27       Impact factor: 3.365

4.  Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.

Authors:  Jon A Detterich; Honglei Liu; Silvie Suriany; Roberta M Kato; Patjanaporn Chalacheva; Bruke Tedla; Payal M Shah; Michael C Khoo; John C Wood; Thomas D Coates; Ginger L Milne; Joo-Yeun Oh; Rakesh P Patel; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2019-07-03       Impact factor: 7.376

5.  Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.

Authors:  Lívia Gelain Castilhos; Juliana Sorraila de Oliveira; Stephen Adeniyi Adefegha; Luana Pereira Magni; Pedro Henrique Doleski; Fatima Husein Abdalla; Cínthia Melazzo de Andrade; Daniela Bitencourt Rosa Leal
Journal:  Redox Rep       Date:  2017-02-16       Impact factor: 4.412

6.  Impaired vasodilation by red blood cells in sickle cell disease.

Authors:  John R Pawloski; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

7.  Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

Authors:  Robert Carter; Joshua Wolf; Tim van Opijnen; Patricia M Flynn; Elaine I Tuomanen; Jason W Rosch; Martha Muller; Caroline Obert; Corinna Burnham; Beth Mann; Yimei Li; Randall T Hayden; Tamara Pestina; Derek Persons; Andrew Camilli
Journal:  Cell Host Microbe       Date:  2014-05-14       Impact factor: 21.023

8.  Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.

Authors:  Claudia R Morris; Jung H Suh; Ward Hagar; Sandra Larkin; D Anton Bland; Martin H Steinberg; Elliott P Vichinsky; Mark Shigenaga; Bruce Ames; Frans A Kuypers; Elizabeth S Klings
Journal:  Blood       Date:  2007-09-11       Impact factor: 22.113

9.  Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis.

Authors:  Yann Ilboudo; Melanie E Garrett; Pablo Bartolucci; Carlo Brugnara; Clary B Clish; Joel N Hirschhorn; Frédéric Galactéros; Allison E Ashley-Koch; Marilyn J Telen; Guillaume Lettre
Journal:  Blood Cells Mol Dis       Date:  2020-09-10       Impact factor: 3.039

Review 10.  Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease.

Authors:  Rani Ashouri; Madison Fangman; Alicia Burris; Miriam O Ezenwa; Diana J Wilkie; Sylvain Doré
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.